News | Mammography | April 03, 2024

The market leader in Operational AI solutions will showcase its new GPT AI solution at the upcoming SBI symposium in Montreal

The market leader in Operational AI solutions will showcase its new GPT AI solution at the upcoming SBI symposium in Montreal

April 3, 2024 — Densitas, a global leader in artificial intelligence solutions for breast cancer screening, announces the commercial release of intelliMaven, a groundbreaking GPT AI assistant for mammography quality. Together with Densitas’ flagship product intelliMammo, intelliMaven provides scalable and sustainable quality assurance for mammography facilities to meet FDA MQSA EQUIP compliance and ACR accreditation requirements.

In an industry-first move, Densitas is revolutionizing the way technologists master their craft. intelliMaven offers bespoke recommendations that align with each technologist's individual learning journey and training needs. This personalized feedback not only accelerates the skill enhancement process but also ensures technologists can refine their positioning techniques with unprecedented efficiency to improve diagnostic accuracy and the standard of patient care.

intelliMaven is designed to support sustainable high-value mammography service delivery at scale by streamlining workflows and fostering a culture of confidence and autonomy among technologists, unlocking new operational efficiencies with expert feedback in real time.

“IntelliMaven is a game-changer. Access to synchronous feedback based on continuous data collection sharpens technologists’ decision-making skills, allowing them greater independence and autonomy, therefore diminishing interruptions for radiologists,” said Dr. Georgia Spear, Chief Breast Imaging at Endeavor Health (Chicago, IL). “Its proficiency in analyzing complex data and summarizing it clearly and succinctly is truly remarkable. This ensures impartial and effective performance reviews. This software doesn’t just add value to daily operations; it redefines them.”

As mammography practices worldwide face an unprecedented staffing crisis, excessive workloads, and alarming burnout rates among technologists and radiologists, intelliMaven is poised to elevate mammography quality standards to:

● Save Time: by transforming complex data into actionable insights swiftly and in easily understood narrative reports, allowing care teams to prioritize patient care and other high-value activities.

● Optimize Radiologists’ Reading Efficiency: by offering immediate and continuous feedback to technologists regarding their performance, and shielding radiologists from frequent interruptions while reading mammograms.

● Mitigate Burnout: by reducing cognitive fatigue and easing decision-making pressures through the automation of data analysis and interpretation, and delivering real-time results and feedback in narrative language.

intelliMaven provides personalized, data-driven training guidance for technologists, paired with expert advice for ongoing skill enhancement in mammography techniques. It also delivers objective, standardized feedback to empower technologists, fostering greater ownership and autonomy in their roles and enhancing job satisfaction.

Discover how intelliMaven can transform your mammography practice at SBI Booth #415. Priority will be given to pre-booked demos. Book yours at https://densitashealth.com/sbi-2024/

For more information: www.densitashealth.com

 

Find more SBI24 conference coverage here


Related Content

News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | FDA

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...

Time June 25, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Pediatric Imaging

June 16, 2026 — Crescom has officially launched a global clinical Proof of Concept (PoC) of its pediatric ...

Time June 24, 2026
arrow
News | Information Technology

June 24, 2026 — HOPPR Presto Agent (Presto) is now commercially available from HOPPR. Presto iis a tool that ntegrates ...

Time June 24, 2026
arrow
Subscribe Now